Metastatic renal cell carcinoma agent nearly doubles survival
Results with personalized immunotherapy support phase III study, authors say...04/25/2013
Source: Kidney Cancer Association - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology